Retour sur lavenir.net
   CFE 13.450 € (+4,67 %)     AB INBEV 73.780 € (-0,89 %)     ARGENX SE 781.800 € (+4,43 %)     KBC ANCORA 80.400 € (+0,12 %)     WDP 22.280 € (-0,71 %)     ONTEX GROUP 2.520 € (+1,61 %)     PROXIMUS 6.105 € (-0,49 %)     RETAIL ESTATES 69.800 € (-0,99 %)     BIOTALYS 3.170 € (+0,32 %)     XIOR 26.400 € (-0,19 %)     CENERGY 24.220 € (-0,41 %)     MELEXIS 79.100 € (-0,32 %)     JENSEN-GROUP 83.000 € (+2,72 %)     TESSENDERLO 19.880 € (+0,10 %)     RECTICEL 10.860 € (0,00 %)     BELYSSE GROUP 0.524 € (-2,96 %)     BREDERODE 103.200 € (+0,98 %)     CMB.TECH 13.140 € (-4,78 %)     VIOHALCO 19.500 € (-5,34 %)     KBC 117.850 € (+0,90 %)     ELIA GROUP 139.700 € (+3,64 %)     TINC 11.380 € (-1,39 %)     CARE PROPERTY INV. 12.540 € (-0,32 %)     SOFINA 219.200 € (-0,81 %)     WHAT'S COOKING GP 144.500 € (-0,34 %)     ACKERMANS V.HAAREN 287.000 € (+0,35 %)     CIE BOIS SAUVAGE 302.000 € (+1,00 %)     VAN DE VELDE 30.200 € (0,00 %)     D'IETEREN GROUP 173.500 € (+3,71 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     GIMV 44.250 € (+0,11 %)     DEME GROUP 177.400 € (-0,78 %)     EVS 27.900 € (-1,24 %)     SHURGARD 25.500 € (+0,99 %)     NYXOAH 1.476 € (+3,07 %)     TUBIZE-FIN 219.800 € (+1,01 %)     DECEUNINCK 2.220 € (+0,91 %)     COFINIMMO 83.150 € (+3,10 %)     UCB 256.600 € (+0,63 %)     GBL 79.100 € (-0,75 %)     BARCO 8.425 € (-0,77 %)     MONTEA 66.100 € (-1,78 %)     SIPEF 92.600 € (+0,22 %)     CAMPINE 214.000 € (-0,93 %)     KINEPOLIS GROUP 35.650 € (+0,71 %)     BPOST 1.560 € (-0,13 %)     SOLVAY 26.980 € (-0,30 %)     SYENSQO 67.000 € (+2,76 %)     ECONOCOM GROUP 1.490 € (-1,00 %)     CELYAD ONCOLOGY 0.250 € (0,00 %)     VGP 84.300 € (+1,57 %)     IBA 16.660 € (+2,33 %)     BEKAERT 40.250 € (+0,37 %)     QRF 11.050 € (-0,90 %)     TITAN S.A. 53.300 € (-0,65 %)     ASCENCIO 52.300 € (0,00 %)     HOME INVEST BE. 19.340 € (+0,10 %)     UMICORE 21.300 € (+1,33 %)     AGEAS 69.400 € (+0,73 %)     IMMOBEL 22.800 € (+0,88 %)  
   EXOSENS 52.650 € (-4,53 %)     EUTELSAT COMMUNIC. 2.160 € (-6,90 %)     STMICROELECTRONICS 65.060 € (+2,68 %)     ASML HOLDING 1 594.000 € (+2,59 %)     GROUPE LDLC 11.840 € (+2,96 %)     GOLD BY GOLD 4.000 € (+0,76 %)     AIRBUS 195.080 € (-0,01 %)     INVIBES ADVERTSING 0.670 € (-1,47 %)     ASR NEDERLAND 66.040 € (-0,03 %)     REXEL 37.300 € (+1,22 %)     SOITEC 112.250 € (+4,61 %)     SEMCO TECHNOLOGIES 48.350 € (-0,51 %)     POSTNL 0.916 € (+0,94 %)     COMPAGNIE ODET 1 492.000 € (+0,81 %)     CEGEDIM 11.200 € (+1,45 %)     XILAM ANIMATION 5.560 € (-10,32 %)     MEDIANTECHNOLOGIES 4.380 € (-8,08 %)     HEINEKEN 73.220 € (-1,80 %)     B.COM.PORTUGUES 1.024 € (0,00 %)     GENFIT 9.570 € (-8,51 %)     LECTRA 16.680 € (+3,09 %)     THALES 218.400 € (-3,06 %)     EXAIL TECHNOLOGIES 93.150 € (-5,81 %)     VICAT 66.900 € (+1,06 %)     CSG 12.350 € (-3,39 %)     ARCADIS 33.040 € (-0,60 %)     ARCELORMITTAL SA 54.280 € (+0,11 %)     BOUYGUES 50.140 € (+1,21 %)     ENTECH 10.560 € (-0,56 %)     ACCSYS 0.882 € (-2,00 %)     WOLTERS KLUWER 55.820 € (-0,78 %)     DSM FIRMENICH AG 80.500 € (-0,59 %)     2CRSI 25.480 € (-4,21 %)     KERING 267.900 € (+0,96 %)     STEF 116.000 € (-0,34 %)     EXEL INDUSTRIES 20.600 € (-2,37 %)     TOTALENERGIES 69.270 € (-0,35 %)     BIOMERIEUX 70.100 € (+2,86 %)     NANOBIOTIX 29.960 € (-0,73 %)     SCHNEIDER ELECTRIC 279.550 € (-0,34 %)     NEXITY 8.000 € (+0,38 %)     PHILIPS KON 23.930 € (+1,23 %)     AKZO NOBEL 61.320 € (+0,82 %)     IMPLANET 0.160 € (-10,01 %)     THERACLION 0.659 € (-0,15 %)     BNP PARIBAS ACT.A 103.000 € (+1,52 %)     AMG 33.420 € (-3,69 %)     SOCIETE GENERALE 78.180 € (+2,84 %)     DBV TECHNOLOGIES 2.820 € (-0,77 %)     ASM INTERNATIONAL 991.000 € (+2,25 %)     CRCAM SUD R.A.CCI 238.500 € (-1,47 %)     PERNOD RICARD 66.000 € (-0,36 %)     AYVENS 11.560 € (+0,52 %)     KAUFMAN ET BROAD 23.950 € (-0,62 %)     VALBIOTIS 0.803 € (-5,53 %)     ABN AMRO BANK N.V. 36.930 € (+0,82 %)     UNILEVER 53.180 € (+0,82 %)     TONNER DRONES 0.025 € (-6,82 %)     LVMH 494.400 € (+0,28 %)     FLOW TRADERS 25.820 € (-0,69 %)  
VINCI
DG - FR0000125486 - Euronext Paris
131,350 €  17:35
+1,70 %
25/06/2026 17:50

VINCI Construction to build the second building of the New Reims Hospital

This press release is an official information document of the VINCI Group.

Nanterre, 25 June 2026

VINCI Construction to build the second building of the New Reims Hospital

  • Construction of the second building in the New Reims Hospital complex for the CHU de Reims
  • A €210 million contract

The Centre Hospitalier Universitaire (CHU) de Reims has entrusted VINCI Construction with the contract to build the second building in the New Reims Hospital complex. The works contract is worth a total €210 million (excl. tax), €157 million of which will go to VINCI Construction. The project execution has been entrusted to a consortium led by Pargade Architectes.

The works are scheduled to last 45 months, during which the hospital must remain in ordinary working order, and primarily involve the construction of a 58,000 m² building spanning seven floors that will accommodate 498 beds, reception and diagnosis areas, high-tech medical platforms, an in-patient zone, a hospital pharmacy, as well as logistics and technical control rooms. The building, named after Madeleine Brès, the first French woman to obtain a medical degree, will mainly house medical activities, including chronic diseases and neuroscience. It will be connected to the existing buildings in the hospital complex to ensure continuity of flow across the site.

The New Reims Hospital project intends to upgrade the healthcare provided by the CHU, in particular thanks to cutting-edge equipment, enhanced quality of care for out-patients and an improved service for in-patients. The teams from VINCI Construction were already involved in the construction of the first building for the New Reims Hospital complex.

This new contract further underscores the recognition enjoyed by the VINCI Group in healthcare infrastructure. In France, the teams from VINCI Construction are also involved in the construction of the “New Lariboisière” building for Assistance Publique – Hôpitaux de Paris (AP-HP), the new CHU in Nantes, the new Hôpital Métropolitain de l’Artois in Lens, as well as the reconstruction of the Chaumont Hospital, Caen CHU and AP-HP’s Hôtel-Dieu hospital.

The teams from VINCI Energies are also involved in many hospital-related contracts and technical works packages.

About VINCI

VINCI is a world leader in concessions, energy solutions and construction, employing 294,000 people in more than 120 countries. We design, finance, build and operate infrastructure and facilities that help improve daily life and mobility for all. Because we believe in all-round performance, above and beyond economic and financial results, we are committed to operating in an environmentally and socially responsible manner. And because our projects are in the public interest, we consider that reaching out to all our stakeholders and engaging in dialogue with them is essential in the conduct of our business activities. VINCI’s ambition is to create long-term value for its customers, shareholders, employees, partners and society in general. www.vinci.com

About the Reims CHU

Drawing on the expertise of its 7,600 professionals, the University Hospital of Reims provides high-quality healthcare in a wide range of medical and surgical specialisms and obstetrics. The patients benefit from an innovative healthcare pathway, enhanced in particular by the development of artificial intelligence and different research protocols. The establishment also includes a 900-bed nursing home facility. Moreover, it plays a key role as a teaching hospital, integrating over 2,300 students. Engaged in a dynamic regional cooperation policy, the CHU also serves as a support establishment to the Champagne University Hospital Group. In order to upgrade its healthcare provision capabilities, it is undertaking a vast property development project, investing €564 million. www.chu-reims.fr

CONTACT

VINCI Press Department - Tel.: +33 1 57 98 62 88 - media.relations@vinci.com

Reims CHU Press Department, Perrine Janson – Tel.: +33 6 77 54 07 20 - pjanson@chu-reims.fr

PRESS RELEASE

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière